Protective Effect of Candesartan on Podocyte Damage in Rats with Diabetic Nephropathy

LI Gui-xia,ZHOU Jing,LI Qiu-yue,LV Jin-lei,LI Liu-sheng
DOI: https://doi.org/10.3969/j.issn.1000-2294.2011.04.008
2011-01-01
Abstract:Objective To investigate the changes in podocyte ultrastructure and nephrin expression in rats with diabetic nephropathy(DN),and to observe the effect of candesartan on podocyte damage.Methods Thirty-six Sprague-Dawley rats were randomly divided into normal control group(group A),DN model group(group B),and candesartan treatment group(group C),with 12 rats in each group.DN was induced by intravenous injection of streptozotocin(30 mg·kg-1) and rats in group C were intragastricly given candesartan(5 mg·kg-1·d-1) 1 week after induction of DN.Rats in group A and group B were given the same amount of normal saline.Blood glucose levels,body weight,24-hour urinary protein excretion and endogenous creatinine clearance(Ccr) were measured at 4 and 7 weeks after treatment.Pathological changes in renal tissues were evaluated by HE staining and podocyte ultrastructure was observed using electron microscop.The expression of nephrin was detected by RT-PCR.Results Compared with group A,24-hour urinary protein excretion and serum creatinine increased,Ccr decreased at 7 weeks,and nephrin expression reduced in group B(all P<0.05).Compared with group B,24-hour urinary protein excretion,serum creatinine,foot process width and glomerular basement membrane thickness decreased,and Ccr and nephrin expression increased in group C(all P<0.05).Conclusion DN patients have abnormal podocyte ultrastructure and nephrin expression.Candesartan can protect podocyte damage through up-regulating nephrin expression and improving podocyte ultrastructure.
What problem does this paper attempt to address?